Real-world data for tisagenlecleucel in patients with R/R B-ALL: subgroup analyses from the CIBMTR registry.

Saved in:
Bibliographic Details
Title: Real-world data for tisagenlecleucel in patients with R/R B-ALL: subgroup analyses from the CIBMTR registry.
Authors: John S; Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX., Curran KJ; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY., Hall EM; Division of Pediatric Hematology, Oncology, and Bone Marrow Transplant, Children's Mercy Kansas City, Kansas City, MO.; Department of Pediatrics, University of Missouri-Kansas City, Kansas City, MO., Keating AK; Department of Pediatrics, University of Colorado School of Medicine and Children's Hospital of Colorado, Aurora, CO., Baumeister SHC; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA.; Division of Pediatric Hematology-Oncology, Boston Children's Hospital, Boston, MA.; Harvard Medical School, Boston, MA., Nikiforow S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Driscoll T; Department of Pediatrics, Pediatric Transplant and Cellular Therapy, Duke University, Durham, NC., Moskop A; Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI.; Division of Pediatric Hematology/Oncology/Blood and Marrow Transplant, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI., McNerney KO; Division of Hematology, Oncology, Neuro-oncology, and Stem Cell Transplantation, Lurie Children's Hospital, Chicago, IL., Phillips CL; Department of Pediatrics, Cincinnati Children''s Hospital Medical Center, University of Cincinnati, Cincinnati, OH., Pulsipher MA; Division of Hematology and Oncology, Intermountain Primary Children's Hospital, Huntsman Cancer Institute, Spencer Fox Eccles School of Medicine at The University of Utah, Salt Lake City, UT., Hsieh EM; Division of Hematology/Oncology, Cancer and Blood Disease Institute, Children's Hospital Los Angeles, Los Angeles, CA., Rouce RH; Department of Pediatrics, Baylor College of Medicine, Texas Children's Hospital, Houston, TX., Pasquini MC; Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI., Tiwari R; Novartis Healthcare Pvt Ltd, Hyderabad, India., Willert J; Novartis Pharmaceuticals Corporation, East Hanover, NJ., Ramos R; Novartis Pharmaceuticals Corporation, East Hanover, NJ., Krueger J; Division of Haematology/Oncology/Bone Marrow Transplantation and Cellular Therapy, Department of Paediatrics, The Hospital for Sick Children, Toronto, ON, Canada., Guest E; Division of Pediatric Hematology, Oncology, and Bone Marrow Transplant, Children's Mercy Kansas City, Kansas City, MO., Grupp SA; Division of Oncology, Cell Therapy and Transplant Section, Children's Hospital of Philadelphia, Philadelphia, PA.; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
Source: Blood advances [Blood Adv] 2025 Oct 28; Vol. 9 (20), pp. 5249-5262.
Publication Type: Journal Article
Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2473-9537
DOI:10.1182/bloodadvances.2025015881